Snowball logo
logo
LIMN

Liminatus Pharma, Inc. Class A Common Stock

LIMN NASDAQ
$0.247+$0.0168  (7.3%)

Frequently asked questions

What sector does Liminatus Pharma, Inc. Class A Common Stock (LIMN) operate in?

Liminatus Pharma, Inc. Class A Common Stock belongs to the Other sector and operates in the Biotechnology industry.

What is Liminatus Pharma, Inc. Class A Common Stock (LIMN) current stock price?

As of the latest data, Liminatus Pharma, Inc. Class A Common Stock stock price is $0.25, with a previous close of $0.23. Liminatus Pharma, Inc. Class A Common Stock gained $0.02 in the last trading session, representing a 7.3% increase.

What is Liminatus Pharma, Inc. Class A Common Stock (LIMN) current market capitalization?

Liminatus Pharma, Inc. Class A Common Stock market cap is approximately 145.16 million.

What is Liminatus Pharma, Inc. Class A Common Stock (LIMN) Earnings Per Share (EPS)?

The trailing EPS is -$0.16.

What is Liminatus Pharma, Inc. Class A Common Stock (LIMN) EBITDA?

Liminatus Pharma, Inc. Class A Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -1.80 million.

Does Liminatus Pharma, Inc. Class A Common Stock (LIMN) pay dividends?

No. Liminatus Pharma, Inc. Class A Common Stock does not pay a dividend.

What is Liminatus Pharma, Inc. Class A Common Stock (LIMN) beta (volatility) score?

Liminatus Pharma, Inc. Class A Common Stock has a beta of 0.170, indicating lower volatility than the overall market.